Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-031811
Filing Date
2025-04-03
Accepted
2025-04-03 19:26:36
Documents
1
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2511508-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2511508-1_4seq1.xml 4 4177
  Complete submission text file 0001104659-25-031811.txt   5635
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Issuer) CIK: 0001651407 (see all company filings)

EIN.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address
GRAY WILLIAM GARRETT (Reporting) CIK: 0001692961 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38128 | Film No.: 25811546